000 01465 a2200421 4500
005 20250514162102.0
264 0 _c20040107
008 200401s 0 0 eng d
022 _a0007-0920
024 7 _a10.1038/sj.bjc.6601366
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCameron, D A
245 0 0 _aModerate neutropenia with adjuvant CMF confers improved survival in early breast cancer.
_h[electronic resource]
260 _bBritish journal of cancer
_cNov 2003
300 _a1837-42 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAge of Onset
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aBreast Neoplasms
_xdiagnosis
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aCyclophosphamide
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aMethotrexate
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aNeutropenia
_xchemically induced
650 0 4 _aPrognosis
650 0 4 _aSurvival Analysis
700 1 _aMassie, C
700 1 _aKerr, G
700 1 _aLeonard, R C F
773 0 _tBritish journal of cancer
_gvol. 89
_gno. 10
_gp. 1837-42
856 4 0 _uhttps://doi.org/10.1038/sj.bjc.6601366
_zAvailable from publisher's website
999 _c14350164
_d14350164